SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial] (2013)
- Authors:
- USP affiliated authors: GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM ; MACHADO, UBIRATAN FABRES - ICB
- Unidades: FM; ICB
- DOI: 10.2217/pgs.10.93
- Subjects: INSULINA (RESISTÊNCIA); DIABETES MELLITUS; FARMACOLOGIA CLÍNICA; GENES
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmacogenomics
- ISSN: 1462-2416
- Volume/Número/Paginação/Ano: v. 14, n. 8, p. 847-850, 2013
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CORRÊA-GIANNELLA, Maria Lucia e MACHADO, Ubiratan Fabres. SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial]. Pharmacogenomics. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.13.45. Acesso em: 13 fev. 2026. , 2013 -
APA
Corrêa-Giannella, M. L., & Machado, U. F. (2013). SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial]. Pharmacogenomics. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.2217/pgs.10.93 -
NLM
Corrêa-Giannella ML, Machado UF. SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial] [Internet]. Pharmacogenomics. 2013 ; 14( 8): 847-850.[citado 2026 fev. 13 ] Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.13.45 -
Vancouver
Corrêa-Giannella ML, Machado UF. SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial] [Internet]. Pharmacogenomics. 2013 ; 14( 8): 847-850.[citado 2026 fev. 13 ] Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.13.45 - Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis
- Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells
- Expression analysis of proto-oncogene ret in patients with primary hyperparathyroidism: comparison between hyperplasia, adenoma and carcinoma
- Continuous glucose monitoring system: dawn period calibration does not change accuracy
- Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes
- Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta]
- Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
- Association between tumor GHSR-IA mRNA expression and in vivo response to GHRP-6 in patients with ACTH-dependent Cushing`s syndrome
- Visceral adiposity syndrome
- Polymorphisms in the gene encoding glucose transporter Glut-1 (SLC2A1) and renal disease in type 1 diabetic patients
Informações sobre o DOI: 10.2217/pgs.10.93 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
